Zhou et al42 showed the CD11b+CD33+HLA‐DR−MDSCs was upregulated in both peripheral blood and intratumor tissues and could inhibit CD8+ T‐cell proliferation in patients with HCC. This evidence concerns the gene CD8A and hepatocellular carcinoma.